About Dr John Lawson
Dr John Lawson is a senior and respected Child Neurologist and Epilepsy Specialist based in Sydney, NSW. He completed his medical degree at the University of Newcastle in 1989 and PhD at the Universit ...
Special interests
Qualifications
- Phd (UNSW)
- Fellowship of the Royal Australasian College of Physicians, The Royal Australasian College of Physicians, Australia, 1998
- Bachelor of Medicine, University of Newcastle, Australia, 1990
Awards and Publications
80 peer reviewed publications. Five important and recent below:
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, O'Callaghan FJ, Wong M, Sahebkar F, Checketts D, Knappertz V; GWPCARE6 Study Group. JAMA Neurol. 2021 Mar 1;78(3):285-292. doi: 10.1001/jamaneurol.2020.4607.
Accelerated long-term forgetting in children with genetic generalized epilepsy: The temporal trajectory and contribution of executive skills.
Joplin S, Webster R, Gill D, Barton B, Lawson JA, Mandalis A, Sabaz M, Gascoigne M, Lah S.
Epilepsy Behav. 2020 Dec;113:107471. doi: 10.1016/j.yebeh.2020.107471. Epub 2020 Nov 2.
Congenital subpendymal giant cell astrocytoma in children with tuberous sclerosis complex: growth patterns and neurological outcome.
Chan DL, Kennedy SE, Sarkozy VE, Chung CWT, Flanagan D, Mowat D, Farrar MA, Lawson JA.
Pediatr Res. 2021 May;89(6):1447-1451. doi: 10.1038/s41390-020-1002-7. Epub 2020 Jun 9.
Management of status epilepticus in children prior to medical retrieval: Deviations from the guidelines.Uppal P, Cardamone M, Webber C, Briggs N, Lawson JA.J Paediatr Child Health. 2019 Dec;55(12):1458-1462. doi: 10.1111/jpc.14448. Epub 2019 Mar 28.
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial.
Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Voi M, Fan J, Vaury A, Pelov D, French JA.
Neurol Clin Pract. 2018 Oct;8(5):412-420. doi: 10.1212/CPJ.0000000000000514.